Nanoengineered targeting strategy for cancer immunotherapy.

Yin, Wei-Min; Li, Yu-Wei; Gu, Yun-Qing; Luo, Min

Yin, Wei-Min; Li, Yu-Wei; Gu, Yun-Qing; Luo, Min.

Afiliación

Yin WM; Institute of Pediatrics, Children's Hospital of Fudan University, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, Chin
Li YW; Institute of Pediatrics, Children's Hospital of Fudan University, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, Chin
Gu YQ; Institute of Pediatrics, Children's Hospital of Fudan University, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, Chin
Luo M; Institute of Pediatrics, Children's Hospital of Fudan University, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, Chin

Acta Pharmacol Sin ; 41(7): 902-910, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32398683

Asunto(s)

Anticuerpos Monoclonales Humanizados/uso terapéutico; Inmunoterapia; Ipilimumab/uso terapéutico; Nanomedicina; Neoplasias/terapia; Humanos; Neoplasias/inmunología; Linfocitos T/inmunología

Palabras clave

cancer immunotherapy; cancer vaccine; immune resistance; immunosuppressive microenvironment; nanomedicine; nanovaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanomedicina / Anticuerpos Monoclonales Humanizados / Ipilimumab / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google